Page 19 - Use Listing News Today

As a decision is awaited on the Emergency Use Listing of Covaxin being manufactured in India, a top WHO official has said the process of thoroughly evaluating a vaccine for use and recommending it sometimes takes a longer time.

WHO Chief Scientist Soumya Swaminathan had said earlier that the technical advisory group at WHO will meet on October 26 to consider the Emergency Use Listing for Covaxin.

Soumya Swaminathan had earlier said that the technical advisory group at WHO will meet on October 26

WHO Chief Scientist Soumya Swaminathan had said in a tweet earlier that the technical advisory group at WHO will meet on October 26 to consider the Emergency Use Listing for Covaxin being manufactured by India's Bharat Biotech.

Chinese Foreign Ministry on Friday released the Position Paper on Chinas Cooperation with the United Nations.　

UNITED NATIONS/GENEVA, Oct 22: As a decision is awaited on the Emergency Use Listing of Covaxin being manufactured in India, a top WHO official has said

Speaking to India Today, Bharat Biotech Chairman Dr Krishna Ella said he hopes Covaxin gets included soon in Covid-19 Emergency Use Listing (EUL) by the WHO.

WHO chief Tedros Adhanom Ghebreyesus discussed the issue of the emergency use listing of Bharat Biotech’s Covid-19 vaccine Covaxin and resumption of supplies of the Serum Institute of India-manufactured AstraZeneca vaccine to the COVAX facility among other topics during a telephonic conversation with Health Minister Mansukh Mandaviya.

New Delhi has allegedly delayed committing supplies of Covaxin, India's first state-made coronavirus vaccine, to a W.H.O. vaccine drive.

Health Minister Mandaviya, WHO chief Tedros hold detailed iteraction over Covaxins emergency use listing